Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
Go back to Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders| (NASDAQ: ALLR) | Delayed: 1.22 -0.03 (2.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $ | |||
| Open | $1.32 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $ | |||
| Volume | 209,466 | |||||
| (NASDAQ: ALLR) | Delayed: 1.22 -0.03 (2.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $ | |||
| Open | $1.32 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $ | |||
| Volume | 209,466 | |||||

